FitLinxx has announced that it will discontinue production of its innovative AmpStrip wearable as a publicly available fitness tracker and will focus on the product’s medical applications. It still remains emblazoned on the company site. Launched as a crowdfunding project on Indiegogo, and winner of the ‘Best of CES’ award 215, the device contains a thermometer, accelerometer and heart rate sensor, all packed into a tiny plaster style strip. The AmpStrips are designed to be worn by people with diabetes or other conditions where blood sugar levels can fluctuate rapidly.
FitLinxx has announced that it will discontinue production of its innovative AmpStrip wearable as a publicly available fitness tracker and will focus on the product’s medical applications. Launched as a crowdfunding project on Indiegogo, and winner of the ‘Best of CES’ award 215, the device contains a thermometer, accelerometer and heart rate sensor, all packed into a tiny plaster style strip. The AmpStrips are designed to be worn by people with diabetes or other conditions where blood sugar levels can fluctuate rapidly.